Japan Synthetic Biology Market, till 2035: Industry Trends and Forecasts - Distribution by Type of Product, Type of Tool, Type of Technology, Type of Application, End User and Leading Players

Description

JAPAN SYNTHETIC BIOLOGY MARKET: OVERVIEW

As per Roots Analysis, the Japan synthetic biology market is estimated to grow from USD 0.79 billion in the current year to USD 5.74 billion by 2040 at a CAGR of 15.7% during the forecast period, 2026-2040.

JAPAN SYNTHETIC BIOLOGY MARKET: GROWTH AND TRENDS

Synthetic biology refers to biological systems that are deliberately designed using various molecular technologies and tools to create medicines and other bio-based products. The synthetic biology sector is witnessing notable growth spurred by the increasing adoption of targeted therapies, biologics and biology-derived products. This field allows for the development of custom-engineered organisms, enabling pharmaceutical companies to design vaccines, semi-synthetic drugs, and gain insights into disease mechanisms. Besides pharmaceuticals, there is a noteworthy rise in the interest for synthetic biology in the biotechnology sector, agriculture, and environmental applications. Moreover, the ongoing shift towards biofuels or green fuels and the demand for sustainable or biodegradable products have further fueled market expansion. As synthetic biology technologies mature across various industrial sectors, they are paving the way for the production of sustainable bio-based solutions. In addition, advancements in synthetic biology are broadening their applications as tools for writing, reading, and editing DNA in organisms to produce valuable commodities.

Notably, Japan holds a prominent position in the Asia-Pacific synthetic biology market due to its advanced R&D ecosystem and strategic investments. In addition, several factors contribute to higher market share compared to other regions . Further, health-conscious consumers are driving the demand for sustainable bio-products, such as personalized medicines and eco-materials, amplified by Japan's manufacturing strength and trade partnerships. These elements position Japan as a mature hub amid demographic and cost challenges.

Genomatica has successfully developed a microorganism-based production method (Geno proprietary technology) that transforms renewable sugars from plants into precursors for nylon (100% renewable carbon-sourced nylon-6). The agriculture sector has also seen a rising implementation of synthetic biology for research and development purposes. For instance, Rice University established the Rice Synthetic Biology Institute to foster collaborative research in synthetic biology and translate it into advantageous technologies.

Alongside the increased utilization of synthetic biology in various fields, the high demand for early disease detection and treatment is propelling research and development in advanced genetic technologies. It is worth highlighting that the growing focus on cancer treatment research has promoted the use of synthetic biology. This technology is instrumental in producing enabling products, including glutaminase, arginase, oxidase, dehydrogenase, deiminase, and ribonuclease, which serve as essential components in the evaluation of cancer-causing cells and in the creation of therapies. Given these trends, we anticipate that the synthetic biology market will experience substantial growth throughout the forecast period.

Growth Drivers: Strategic Enablers of Market Expansion

Advancements in CRISPR technology and DNA synthesis are decreasing costs and enhancing accuracy in biological engineering. There is a rising need for bio-derived fuels, materials, and therapeutics as part of decarbonization initiatives, backed by robust academic research and global collaborations. Government regulations and Japan's proficiency in precision engineering are also driving the adoption in the healthcare and manufacturing sectors.

Market Challenges: Critical Barriers Impeding Progress

The expensive nature of platforms and bioprocessing obstructs scaling up, especially for intricate therapies. Regulatory challenges concerning engineered organisms, along with ethical and biosafety issues, delay the arrival of products to the market. A lack of skilled talent in various fields and pushback from conventional industries create obstacles for broader adoption of synthetic Biology in Japan.

Polymerase Chain Reaction (PCR): Leading Market Segment

In terms of type of technology, the Japan synthetic biology market is segmented across PCR Technology, NGS technology, genome editing technology, bioprocessing technology and other technologies. Currently, polymerase chain reaction (PCR) segment captures around 30% of the overall market share, due to its precision, rapidity, and extensive use in identifying infectious diseases, genetic conditions, and cancer. However, the genome editing technology segment is likely to grow at a higher CAGR of 16.6% during the forecast period, which is probably influenced by its capacity to deliver detailed genomic data and sophisticated personalized medical care.

Oligonucleotide / Oligo Pools and Synthetic DNA: Dominating Market Segment

In terms of type of product, the Japan synthetic biology market is segmented across oligonucleotide / oligo pools and synthetic DNAdna, enzymes, cloning technologies kits, chassis organism, and others. Currently, majority (~30%) of the market share is held by oligonucleotide / oligo pools and synthetic DNA. This can be linked to the collection of blood, serum, and plasma in clinical environments, which facilitates large-scale testing and ongoing observation. Additionally, the urine segment is expected to experience a higher compound annual growth rate (CAGR) of 7.1% throughout the forecast period.

Academic and Government Research Institutes: Emerging Market Segment

In terms of end-users, the Japan synthetic biology market is segmented across biotechnology and pharmaceutical companies, academic and government research institutes and others. Currently, majority (~70%) of the market share is held by biotechnology and pharmaceutical companies. However, Academic and Government Research Institutes are anticipated to grow at a higher CAGR of 16.1%.

JAPAN SYNTHETIC BIOLOGY MARKET: KEY SEGMENTS

Type of Product

Core Products
Enabling Products

Type of Tool

Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technology Kits
Synthetic Cells

Type of Technology

Gene Synthesis
Genome Engineering
Microfluidics
Nanotechnology
Sequencing
Bioinformatics
Site-Directed Mutagenesis
Cloning
Measurement and Modeling
Polymerase Chain Reaction

Type of Application

Healthcare
Artificial Tissue & Tissue Regeneration
Industrial
Environmental
Food
Agriculture

End User

Biotechnology and Pharmaceutical companies
Academic and Research Institutes
Other End Users

KEY QUESTIONS ANSWERED IN THIS REPORT

How many synthetic biology solution providers are currently engaged in this market?
Which are the leading companies in this market?
Which country dominates the Japan synthetic biology market?
What are the key trends observed in the Japan synthetic biology market?
What factors are likely to influence the evolution of this market?
What are the primary challenges faced by synthetic biology solution providers in Japan?
What is the current and future Japan synthetic biology market size?
What is the CAGR of Japan synthetic biology market?
How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
The report can aid businesses in identifying future opportunities in any sector. It also helps in understanding if those opportunities are worth pursuing.
The report helps in identifying customer demand by understanding the needs, preferences, and behavior of the target audience in order to tailor products or services effectively.
The report equips new entrants with requisite information regarding a particular market to help them build successful business strategies.
The report allows for more effective communication with the audience and in building strong business relations.

COMPLEMENTARY BENEFITS

Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

Product Code: RAD00022

1. PREFACE

1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
- 2.2.1. Market Landscape and Market Trends
- 2.2.2. Market Forecast and Opportunity Analysis
- 2.2.3. Comparative Analysis
2.3. Database Building
- 2.3.1. Data Collection
- 2.3.2. Data Validation
- 2.3.3. Data Analysis
2.4. Project Methodology
- 2.4.1. Secondary Research
  - 2.4.1.1. Annual Reports
  - 2.4.1.2. Academic Research Papers
  - 2.4.1.3. Company Websites
  - 2.4.1.4. Investor Presentations
  - 2.4.1.5. Regulatory Filings
  - 2.4.1.6. White Papers
  - 2.4.1.7. Industry Publications
  - 2.4.1.8. Conferences and Seminars
  - 2.4.1.9. Government Portals
  - 2.4.1.10. Media and Press Releases
  - 2.4.1.11. Newsletters
  - 2.4.1.12. Industry Databases
  - 2.4.1.13. Roots Proprietary Databases
  - 2.4.1.14. Paid Databases and Sources
  - 2.4.1.15. Social Media Portals
  - 2.4.1.16. Other Secondary Sources
- 2.4.2. Primary Research
  - 2.4.2.1. Types of Primary Research
    - 2.4.2.1.1. Qualitative Research
    - 2.4.2.1.2. Quantitative Research
    - 2.4.2.1.3. Hybrid Approach
  - 2.4.2.2. Advantages of Primary Research
  - 2.4.2.3. Techniques for Primary Research
    - 2.4.2.3.1. Interviews
    - 2.4.2.3.2. Surveys
    - 2.4.2.3.3. Focus Groups
    - 2.4.2.3.4. Observational Research
    - 2.4.2.3.5. Social Media Interactions
  - 2.4.2.4. Key Opinion Leaders Considered in Primary Research
    - 2.4.2.4.1. Company Executives (CXOs)
    - 2.4.2.4.2. Board of Directors
    - 2.4.2.4.3. Company Presidents and Vice Presidents
    - 2.4.2.4.4. Research and Development Heads
    - 2.4.2.4.5. Technical Experts
    - 2.4.2.4.6. Subject Matter Experts
    - 2.4.2.4.7. Scientists
    - 2.4.2.4.8. Doctors and Other Healthcare Providers
  - 2.4.2.5. Ethics and Integrity
    - 2.4.2.5.1. Research Ethics
    - 2.4.2.5.2. Data Integrity
- 2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control

3. MARKET DYNAMICS

3.1. Chapter Overview
3.2. Forecast Methodology
- 3.2.1. Top-down Approach
- 3.2.2. Bottom-up Approach
- 3.2.3. Hybrid Approach
3.3. Market Assessment Framework
- 3.3.1. Total Addressable Market (TAM)
- 3.3.2. Serviceable Addressable Market (SAM)
- 3.3.3. Serviceable Obtainable Market (SOM)
- 3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
- 3.4.1. Qualitative Forecasting
- 3.4.2. Correlation
- 3.4.3. Regression
- 3.4.4. Extrapolation
- 3.4.5. Convergence
- 3.4.6. Sensitivity Analysis
- 3.4.7. Scenario Planning
- 3.4.8. Data Visualization
- 3.4.9. Time Series Analysis
- 3.4.10. Forecast Error Analysis
3.5. Key Considerations
- 3.5.1. Demographics
- 3.5.2. Government Regulations
- 3.5.3. Reimbursement Scenarios
- 3.5.4. Market Access
- 3.5.5. Supply Chain
- 3.5.6. Industry Consolidation
- 3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations

4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview
4.2. Market Dynamics
- 4.2.1. Time Period
  - 4.2.1.1. Historical Trends
  - 4.2.1.2. Current and Forecasted Estimates
- 4.2.2. Currency Coverage
  - 4.2.2.1. Major Currencies Affecting the Market
  - 4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
  - 4.2.2.3. Impact of Currency Fluctuations on the Industry
- 4.2.3. Foreign Currency Exchange Rate
  - 4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
  - 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
- 4.2.4. Recession
  - 4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
  - 4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
- 4.2.5. Inflation
  - 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
  - 4.2.5.2. Potential Impact of Inflation on the Market Evolution
- 4.2.6. Interest Rates
  - 4.2.6.1. Interest Rates and Their Impact on the Market
  - 4.2.6.2. Strategies for Managing Interest Rate Risk
- 4.2.7. Commodity Flow Analysis
  - 4.2.7.1. Type of Commodity
  - 4.2.7.2. Origins and Destinations
  - 4.2.7.3. Value and Weights
  - 4.2.7.4. Modes of Transportation
- 4.2.8. Global Trade Dynamics
  - 4.2.8.1. Import Scenario
  - 4.2.8.2. Export Scenario
  - 4.2.8.3. Trade Policies
  - 4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
  - 4.2.8.5. Impact of Trade Barriers on the Market
- 4.2.9. War Impact Analysis
  - 4.2.9.1. Russian-Ukraine War
  - 4.2.9.2. Israel-Hamas War
- 4.2.10. COVID Impact / Related Factors
  - 4.2.10.1. Global Economic Impact
  - 4.2.10.2. Industry-specific Impact
  - 4.2.10.3. Government Response and Stimulus Measures
  - 4.2.10.4. Future Outlook and Adaptation Strategies
- 4.2.11. Other Indicators
  - 4.2.11.1. Fiscal Policy
  - 4.2.11.2. Consumer Spending
  - 4.2.11.3. Gross Domestic Product (GDP)
  - 4.2.11.4. Employment
  - 4.2.11.5. Taxes
  - 4.2.11.6. Stock Market Performance
  - 4.2.11.7. Cross-Border Dynamics
4.3. Conclusion

5. EXECUTIVE SUMMARY

6. INTRODUCTION

6.1. Chapter Overview
6.2. Overview of the Synthetic Biology Industry
6.3. Classification of Synthetic Biology
6.4. Advantages of Synthetic Biology
6.5. Key Application Areas of Synthetic Biology
6.6. Future Perspectives

7. MARKET LANDSCAPE

7.1. Chapter Overview
7.2. Japan Synthetic Biology Market: Overall Market Landscape
- 7.2.1. Analysis by Year of Establishment
- 7.2.2. Analysis by Company Size
- 7.2.3. Analysis by Location of Headquarters
- 7.2.4. Analysis by Ownership Structure
- 7.2.5. Analysis by Type of Technology
- 7.2.6. Analysis by Application Area
- 7.2.7. Analysis by End-user

8. COMPANY COMPETITIVENESS ANALYSIS

8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Japan Synthetic Biology Solution Providers: Company Competitiveness Analysis
- 8.4.1. Small Japan Synthetic Biology Solution Providers (Peer Group I)
- 8.4.2. Mid-sized Japan Synthetic Biology Solution Providers (Peer Group II)
- 8.4.3. Large Japan Synthetic Biology Solution Providers (Peer Group III)
8.5. Capability Benchmarking of top Japan Synthetic Biology Solution Providers

9. COMPANY PROFILES: JAPAN SYNTHETIC BIOLOGY MARKET

9.1. Chapter Overview
9.2. Amyris
- 9.2.1. Company Overview
- 9.2.2. Product Portfolio
- 9.2.3. Financial Information
- 9.2.4. Recent Developments and Future Outlook
9.3. Bruker Cellular Analysis
9.4. Bico
9.5. Codexis
9.6. Ginkgo Bioworks
9.7. GenScript Biotech
9.8. Integrated DNA Technologies
9.9. Insitro
9.10. Novozymes
9.11. Zymergen

10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview
10.2. Partnership Models
10.3. Japan Synthetic Biology Solution Providers: Partnerships and Collaborations
- 10.3.1. Analysis by Year of Partnership
- 10.3.2. Analysis by Type of Partnership
- 10.3.3. Most Active Players: Analysis by Number of Partnerships
- 10.3.4. Analysis by Geography
  - 10.3.4.1. Intercontinental and Intracontinental Agreements
  - 10.3.4.2. Local and International Agreements

11. MARKET IMPACT ANALYSIS

11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. JAPAN SYNTHETIC BIOLOGY MARKET

12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Japan Synthetic Biology Market: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)
12.4. Roots Analysis Perspective on Market Growth
12.5 Scenario Analysis
- 12.5.1. Conservative Scenario
- 12.5.2. Optimistic Scenario
12.6. Key Market Segmentations

13. JAPAN SYNTHETIC BIOLOGY MARKET, BY TYPE OF PRODUCT

13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Japan Synthetic Biology Market: Distribution by Type of Product
- 13.3.1. Japan Synthetic Biology Market for Core Products: Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
- 13.3.2. Japan Synthetic Biology Market for Enabling Products, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
13.4. Data Triangulation and Validation

14. JAPAN SYNTHETIC BIOLOGY MARKET, BY TYPE OF TOOL

14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Japan Synthetic Biology Market: Distribution by Type of Tool
- 14.3.1. Japan Synthetic Biology Market for Oligonucleotides and Synthetic DNA, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
- 14.3.2. Japan Synthetic Biology Market for Enzymes, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
- 14.3.3. Japan Synthetic Biology Market for Cloning Technology Kits, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
- 14.3.4. Japan Synthetic Biology Market for Synthetic Cells, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
14.4. Data Triangulation and Validation

15. JAPAN SYNTHETIC BIOLOGY MARKET, BY TYPE OF TECHNOLOGY

15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Japan Synthetic Biology Market: Distribution by Type of Technology
- 15.3.1. Japan Synthetic Biology Market for Gene Synthesis, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.2. Japan Synthetic Biology Market for Genome Engineering, (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.3. Japan Synthetic Biology Market for Microfluidics, (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.4. Japan Synthetic Biology Market for Nanotechnology, (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.5. Japan Synthetic Biology Market for Sequencing, (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.6. Japan Synthetic Biology Market for Bioinformatics, (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.7. Japan Synthetic Biology Market for Site-Directed Mutagenesis, (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.8. Japan Synthetic Biology Market for Cloning, (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.9. Japan Synthetic Biology Market for Measurement and Modeling, (Since 2023) and Forecasted Estimates (Till 2035)
- 15.3.10. Japan Synthetic Biology Market for Polymerase Chain Reaction, (Since 2023) and Forecasted Estimates (Till 2035)
15.4. Data Triangulation and Validation

16. JAPAN SYNTHETIC BIOLOGY MARKET, BY TYPE OF APPLICATION

16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Japan Synthetic Biology Market: Distribution by Type of Application
- 16.3.1. Japan Synthetic Biology Market for Healthcare, (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
- 16.3.2. Japan Synthetic Biology Market for Artificial Tissue and Tissue Regeneration, (Since 2023) and Forecasted Estimates (Till 2035)
- 16.3.3. Japan Synthetic Biology Market for Industrial Applications, (Since 2023) and Forecasted Estimates (Till 2035)
- 16.3.4. Japan Synthetic Biology Market for Environmental Applications, (Since 2023) and Forecasted Estimates (Till 2035)
- 16.3.5. Japan Synthetic Biology Market for Food, (Since 2023) and Forecasted Estimates (Till 2035)
- 16.3.6. Japan Synthetic Biology Market for Agriculture, (Since 2023) and Forecasted Estimates (Till 2035)
16.4. Data Triangulation and Validation

17. JAPAN SYNTHETIC BIOLOGY MARKET, BY END USERS

17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Japan Synthetic Biology Market: Distribution by End Users (Current Year and 2035)
- 17.3.2. Japan Synthetic Biology Market for Biotechnology and Pharmaceutical Companies (Since 2023) and Forecasted Estimates (Till 2035)
- 17.3.3. Japan Synthetic Biology Market for Academic and Research Institutes, (Since 2023) and Forecasted Estimates (Till 2035)
- 17.3.4. Japan Synthetic Biology Market for Other End Users, (Since 2023) and Forecasted Estimates (Till 2035)
17.4. Data Triangulation and Validation